Search research articles
Contact Us
Filters
Showing results (71-80 of 95) with videos related to
Page
of 10
Sort By:
International Journal of Molecular Sciences
|
February 26, 2022
In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical Screening
Nunzio Iraci, Carmine Ostacolo, Alicia Medina-Peris, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
March 26, 2013
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide
Alfonso Carotenuto, Luigia Auriemma, Francesco Merlino, et al.
European Journal of Medicinal Chemistry
|
October 1, 2016
Identification of novel microsomal prostaglandin E<sub>2</sub> synthase-1 (mPGES-1) lead inhibitors from Fragment Virtual Screening
Gianluigi Lauro, Michele Manfra, Silvana Pedatella, et al.
Plos One
|
April 30, 2013
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity
Paolo Grieco, Alfonso Carotenuto, Luigia Auriemma, et al.
Plos One
|
August 27, 2013
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor
Barbara Costa, Sara Bendinelli, Pamela Gabelloni, et al.
Journal of Medicinal Chemistry
|
May 11, 2011
Design, synthesis, and cytotoxic evaluation of acyl derivatives of 3-aminonaphtho[2,3-b]thiophene-4,9-dione, a quinone-based system
Isabel Gomez-Monterrey, Pietro Campiglia, Claudio Aquino, et al.
Journal of Medicinal Chemistry
|
June 28, 2013
Synthesis, in vitro, and in cell studies of a new series of [indoline-3,2'-thiazolidine]-based p53 modulators
Alessia Bertamino, Maria Soprano, Simona Musella, et al.
Journal of Medicinal Chemistry
|
May 13, 2009
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide
Paolo Grieco, Alfonso Carotenuto, Pietro Campiglia, et al.
Journal of Medicinal Chemistry
|
November 10, 2010
Identification of the spiro(oxindole-3,3'-thiazolidine)-based derivatives as potential p53 activity modulators
Isabel Gomez-Monterrey, Alessia Bertamino, Amalia Porta, et al.
Plos One
|
June 26, 2015
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy
Ersilia Cipolletta, Maria Rosaria Rusciano, Angela Serena Maione, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 95) with videos related to
Sort By:
Page
of 10
International Journal of Molecular Sciences
|
February 26, 2022
In Vitro and In Vivo Pharmacological Characterization of a Novel TRPM8 Inhibitor Chemotype Identified by Small-Scale Preclinical Screening
Nunzio Iraci, Carmine Ostacolo, Alicia Medina-Peris, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society
|
March 26, 2013
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide
Alfonso Carotenuto, Luigia Auriemma, Francesco Merlino, et al.
European Journal of Medicinal Chemistry
|
October 1, 2016
Identification of novel microsomal prostaglandin E<sub>2</sub> synthase-1 (mPGES-1) lead inhibitors from Fragment Virtual Screening
Gianluigi Lauro, Michele Manfra, Silvana Pedatella, et al.
Plos One
|
April 30, 2013
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity
Paolo Grieco, Alfonso Carotenuto, Luigia Auriemma, et al.
Plos One
|
August 27, 2013
Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor
Barbara Costa, Sara Bendinelli, Pamela Gabelloni, et al.
Journal of Medicinal Chemistry
|
May 11, 2011
Design, synthesis, and cytotoxic evaluation of acyl derivatives of 3-aminonaphtho[2,3-b]thiophene-4,9-dione, a quinone-based system
Isabel Gomez-Monterrey, Pietro Campiglia, Claudio Aquino, et al.
Journal of Medicinal Chemistry
|
June 28, 2013
Synthesis, in vitro, and in cell studies of a new series of [indoline-3,2'-thiazolidine]-based p53 modulators
Alessia Bertamino, Maria Soprano, Simona Musella, et al.
Journal of Medicinal Chemistry
|
May 13, 2009
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide
Paolo Grieco, Alfonso Carotenuto, Pietro Campiglia, et al.
Journal of Medicinal Chemistry
|
November 10, 2010
Identification of the spiro(oxindole-3,3'-thiazolidine)-based derivatives as potential p53 activity modulators
Isabel Gomez-Monterrey, Alessia Bertamino, Amalia Porta, et al.
Plos One
|
June 26, 2015
Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy
Ersilia Cipolletta, Maria Rosaria Rusciano, Angela Serena Maione, et al.
Page
of 10